MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 222 filers reported holding MIRATI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,466,351 | +64.7% | 148,447 | +36.6% | 0.00% | +100.0% |
| Q2 2023 | $3,926,355 | +3.6% | 108,673 | +6.6% | 0.00% | 0.0% |
| Q1 2023 | $3,791,096 | +13.6% | 101,966 | +38.5% | 0.00% | 0.0% |
| Q4 2022 | $3,336,720 | -27.2% | 73,642 | +12.1% | 0.00% | 0.0% |
| Q3 2022 | $4,586,000 | -2.8% | 65,676 | -6.6% | 0.00% | 0.0% |
| Q2 2022 | $4,720,000 | -37.2% | 70,318 | -23.1% | 0.00% | -50.0% |
| Q1 2022 | $7,521,000 | -18.5% | 91,464 | +45.4% | 0.00% | 0.0% |
| Q4 2021 | $9,230,000 | -81.8% | 62,917 | -78.0% | 0.00% | -81.8% |
| Q3 2021 | $50,592,000 | -3.9% | 285,982 | -12.2% | 0.01% | -8.3% |
| Q2 2021 | $52,629,000 | -5.1% | 325,812 | +0.6% | 0.01% | 0.0% |
| Q1 2021 | $55,473,000 | -15.9% | 323,835 | +7.8% | 0.01% | -25.0% |
| Q4 2020 | $65,950,000 | +88.7% | 300,266 | +42.7% | 0.02% | +60.0% |
| Q3 2020 | $34,951,000 | +421.5% | 210,479 | +258.6% | 0.01% | +400.0% |
| Q2 2020 | $6,702,000 | +92.3% | 58,699 | +29.5% | 0.00% | +100.0% |
| Q1 2020 | $3,485,000 | -32.8% | 45,334 | +12.6% | 0.00% | 0.0% |
| Q4 2019 | $5,188,000 | -74.6% | 40,261 | -84.7% | 0.00% | -83.3% |
| Q3 2019 | $20,449,000 | -25.9% | 262,468 | -2.1% | 0.01% | -25.0% |
| Q2 2019 | $27,602,000 | +9.0% | 267,983 | -22.4% | 0.01% | 0.0% |
| Q1 2019 | $25,313,000 | +69.1% | 345,349 | -2.1% | 0.01% | +60.0% |
| Q4 2018 | $14,968,000 | +20.9% | 352,840 | +34.2% | 0.01% | +25.0% |
| Q3 2018 | $12,382,000 | +2304.3% | 262,881 | +2414.9% | 0.00% | – |
| Q2 2018 | $515,000 | +625.4% | 10,453 | +350.4% | 0.00% | – |
| Q1 2018 | $71,000 | +446.2% | 2,321 | +231.6% | 0.00% | – |
| Q4 2017 | $13,000 | +62.5% | 700 | 0.0% | 0.00% | – |
| Q3 2017 | $8,000 | -89.2% | 700 | -95.1% | 0.00% | – |
| Q1 2017 | $74,000 | +428.6% | 14,224 | +386.5% | 0.00% | – |
| Q4 2016 | $14,000 | -36.4% | 2,924 | -14.6% | 0.00% | – |
| Q3 2016 | $22,000 | +37.5% | 3,424 | +17.1% | 0.00% | – |
| Q2 2016 | $16,000 | -82.6% | 2,924 | -32.6% | 0.00% | – |
| Q1 2016 | $92,000 | -22.7% | 4,336 | +15.8% | 0.00% | – |
| Q4 2015 | $119,000 | -5.6% | 3,743 | +2.0% | 0.00% | – |
| Q3 2015 | $126,000 | -2.3% | 3,668 | -10.5% | 0.00% | – |
| Q2 2015 | $129,000 | -6.5% | 4,100 | -12.3% | 0.00% | – |
| Q1 2015 | $138,000 | +626.3% | 4,674 | +362.8% | 0.00% | – |
| Q4 2014 | $19,000 | +5.6% | 1,010 | +0.3% | 0.00% | – |
| Q3 2014 | $18,000 | -25.0% | 1,007 | -15.2% | 0.00% | – |
| Q2 2014 | $24,000 | -64.7% | 1,187 | -66.6% | 0.00% | – |
| Q1 2014 | $68,000 | +518.2% | 3,559 | +425.7% | 0.00% | – |
| Q4 2013 | $11,000 | +10.0% | 677 | 0.0% | 0.00% | – |
| Q3 2013 | $10,000 | – | 677 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |